Aeterna Zentaris Inc. – NASDAQ:AEZS

Financial Health
0
1
2
3
4
5
6
7
8
9

Aeterna Zentaris stock price monthly change

-4.96%
month

Aeterna Zentaris stock price quarterly change

+203.85%
quarter

Aeterna Zentaris stock price yearly change

+130.66%
year

Aeterna Zentaris key metrics

Market Cap
17.51M
Enterprise value
N/A
P/E
-0.56
EV/Sales
-6.17
EV/EBITDA
3.07
Price/Sales
1.93
Price/Book
0.25
PEG ratio
-0.01
EPS
-21.43
Revenue
2.37M
EBITDA
-19.90M
Income
-18.18M
Revenue Q/Q
-99.81%
Revenue Y/Y
-61.96%
Profit margin
-203.11%
Oper. margin
-221.38%
Gross margin
98.13%
EBIT margin
-221.38%
EBITDA margin
-837.14%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Aeterna Zentaris stock price history

Aeterna Zentaris stock forecast

Aeterna Zentaris financial statements

Aeterna Zentaris Inc. (NASDAQ:AEZS): Profit margin
Jun 2023 2.24M -2.51M -112.11%
Sep 2023 3K -4.14M -138166.67%
Dec 2023 124.34K -5.79M -4657.03%
Mar 2024 3.98K -5.72M -143804.75%
Aeterna Zentaris Inc. (NASDAQ:AEZS): Debt to assets
Jun 2023 46483000 17.40M 37.44%
Sep 2023 42486000 16.20M 38.15%
Dec 2023 36826615 18.72M 50.84%
Mar 2024 31759227 18.80M 59.2%
Aeterna Zentaris Inc. (NASDAQ:AEZS): Cash Flow
Jun 2023 -4.29M -3K -42K
Sep 2023 -3.38M -10K -33K
Dec 2023 -5.50M 552.92K -38.93K
Mar 2024 -4.27M -4.97K -41.81K

Aeterna Zentaris alternative data

Aeterna Zentaris Inc. (NASDAQ:AEZS): Employee count
Aug 2023 12
Sep 2023 12
Oct 2023 12
Nov 2023 12
Dec 2023 12
Jan 2024 12
Feb 2024 12
Mar 2024 12
Apr 2024 12
May 2024 12
Jun 2024 12
Jul 2024 12

Aeterna Zentaris other data

0.18% -0.54%
of AEZS is owned by hedge funds
8.89K -26.05K
shares is hold by hedge funds
Tuesday, 6 August 2024
globenewswire.com
Tuesday, 16 July 2024
globenewswire.com
Thursday, 13 June 2024
globenewswire.com
Friday, 7 June 2024
prnewswire.com
Monday, 3 June 2024
globenewswire.com
Wednesday, 29 May 2024
globenewswire.com
Friday, 17 May 2024
globenewswire.com
Tuesday, 14 May 2024
globenewswire.com
Wednesday, 1 May 2024
globenewswire.com
Thursday, 28 March 2024
globenewswire.com
Wednesday, 27 March 2024
Zacks Investment Research
Thursday, 23 March 2023
Zacks Investment Research
Tuesday, 7 February 2023
Zacks Investment Research
Tuesday, 10 January 2023
GlobeNewsWire
Wednesday, 18 May 2022
GlobeNewsWire
Monday, 7 February 2022
GlobeNewsWire
Thursday, 20 January 2022
GlobeNewsWire
Wednesday, 5 January 2022
GlobeNewsWire
Friday, 1 October 2021
InvestorPlace
Wednesday, 8 September 2021
GlobeNewsWire
  • When is Aeterna Zentaris's next earnings date?

    Unfortunately, Aeterna Zentaris's (AEZS) next earnings date is currently unknown.

  • Does Aeterna Zentaris pay dividends?

    No, Aeterna Zentaris does not pay dividends.

  • How much money does Aeterna Zentaris make?

    Aeterna Zentaris has a market capitalization of 17.51M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 18.79% to 4.58M US dollars.

  • What is Aeterna Zentaris's stock symbol?

    Aeterna Zentaris Inc. is traded on the NASDAQ under the ticker symbol "AEZS".

  • What is Aeterna Zentaris's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Aeterna Zentaris?

    Shares of Aeterna Zentaris can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Aeterna Zentaris have?

    As Jul 2024, Aeterna Zentaris employs 12 workers.

  • When Aeterna Zentaris went public?

    Aeterna Zentaris Inc. is publicly traded company for more then 25 years since IPO on 10 May 2000.

  • What is Aeterna Zentaris's official website?

    The official website for Aeterna Zentaris is zentaris.com.

  • Where are Aeterna Zentaris's headquarters?

    Aeterna Zentaris is headquartered at 315 Sigma Drive, Summerville, SC.

  • How can i contact Aeterna Zentaris?

    Aeterna Zentaris's mailing address is 315 Sigma Drive, Summerville, SC and company can be reached via phone at +84 39003223.

Aeterna Zentaris company profile:

Aeterna Zentaris Inc.

zentaris.com
Exchange:

NASDAQ

Full time employees:

12

Industry:

Biotechnology

Sector:

Healthcare

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

315 Sigma Drive
Summerville, SC 29486

CIK: 0001113423
ISIN: CA0079755017
CUSIP: 007975402